Easy to manufacture and update, these new vaccines may be a powerful tool against emerging variants and other infectious diseases| The Hub
Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for a range of diseases, and why federal research cuts risk undermining U.S. scientific leadership in this emerging area| The Hub
Federal funding for biomedical research pays off by enabling basic discoveries that lead to lifesaving treatments, writes Hopkins biologist Jeff Coller| The Hub
Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels of specific cellular proteins| The Hub